NO982112L - Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor og en kalsiumkanal antagonist, fremgangsmÕte for fremstilling og anvendelse derav i behandling av kardiovaskulµre sykdommer - Google Patents

Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor og en kalsiumkanal antagonist, fremgangsmÕte for fremstilling og anvendelse derav i behandling av kardiovaskulµre sykdommer

Info

Publication number
NO982112L
NO982112L NO982112A NO982112A NO982112L NO 982112 L NO982112 L NO 982112L NO 982112 A NO982112 A NO 982112A NO 982112 A NO982112 A NO 982112A NO 982112 L NO982112 L NO 982112L
Authority
NO
Norway
Prior art keywords
preparation
treatment
calcium channel
cardiovascular diseases
converting enzyme
Prior art date
Application number
NO982112A
Other languages
English (en)
Other versions
NO982112D0 (no
NO315545B1 (no
Inventor
Pedro Canovas Soler
Joaquin Delgadillo Duarte
Luis Manuel Micheto Escuder
Original Assignee
Vita Invest Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8299270&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO982112(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vita Invest Sa filed Critical Vita Invest Sa
Publication of NO982112D0 publication Critical patent/NO982112D0/no
Publication of NO982112L publication Critical patent/NO982112L/no
Publication of NO315545B1 publication Critical patent/NO315545B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
NO19982112A 1997-05-13 1998-05-08 Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor ogav en kalsiumkanal antagonist, fremgangsmåte for fremstilling oganvendelse derav ved behandling av kardiovaskul¶re sykdommer NO315545B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701017A ES2125198B1 (es) 1997-05-13 1997-05-13 Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.

Publications (3)

Publication Number Publication Date
NO982112D0 NO982112D0 (no) 1998-05-08
NO982112L true NO982112L (no) 1998-11-16
NO315545B1 NO315545B1 (no) 2003-09-22

Family

ID=8299270

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982112A NO315545B1 (no) 1997-05-13 1998-05-08 Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor ogav en kalsiumkanal antagonist, fremgangsmåte for fremstilling oganvendelse derav ved behandling av kardiovaskul¶re sykdommer

Country Status (23)

Country Link
EP (1) EP0884054B9 (no)
JP (1) JP3576806B2 (no)
CN (1) CN1146418C (no)
AR (1) AR011730A1 (no)
AT (1) ATE236653T1 (no)
AU (1) AU735404B2 (no)
BR (1) BR9805597A (no)
CA (1) CA2234899C (no)
CZ (1) CZ292616B6 (no)
DE (1) DE69813083T2 (no)
DK (1) DK0884054T3 (no)
ES (2) ES2125198B1 (no)
HU (1) HUP9801075A3 (no)
IL (1) IL124253A (no)
NO (1) NO315545B1 (no)
NZ (1) NZ330447A (no)
PL (1) PL192117B1 (no)
PT (1) PT884054E (no)
RU (1) RU2182002C2 (no)
SK (1) SK284337B6 (no)
TR (1) TR199800847A2 (no)
TW (1) TW562679B (no)
ZA (1) ZA983806B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
BR0109991A (pt) * 2000-04-11 2003-05-27 Sankyo Co Composição farmacêutica
IL156445A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US20060018959A1 (en) * 2002-12-16 2006-01-26 Kissei Pharmaceutical Co. Ltd. Solid drug for oral use
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
CN109350733A (zh) * 2018-06-08 2019-02-19 山东理工职业学院 一种马来酸依那普利片剂的制备方法
CN109985013B (zh) * 2019-05-10 2021-08-10 河北君圣药业有限公司 一种尼群地平分散片及其制备方法
CN115501224A (zh) * 2022-10-09 2022-12-23 南昌大学第一附属医院 马来酸依那普利叶酸片联合通心络在制备治疗高血压合并颈动脉硬化药物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
USH734H (en) * 1988-03-07 1990-02-06 E. R. Squibb & Sons, Inc. Method for inhibiting onset of or treating migraine headaches employing an ACE inhibitor
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
CA2007525A1 (en) * 1989-01-30 1990-07-30 Zola P. Horovitz Method for facilating dieting employing an ace inhibitor
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
YU48602B (sh) * 1991-11-25 1998-12-23 Krka Tovarna Zdravil P.O. Postupak za dobijanje stabilne formulacije soli enalaprila
SI9300504A (en) * 1993-09-28 1995-04-30 Krka Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof

Also Published As

Publication number Publication date
CZ138198A3 (cs) 1998-12-16
EP0884054B9 (en) 2007-02-14
DK0884054T3 (da) 2003-07-21
AU6597398A (en) 1998-11-19
CN1212869A (zh) 1999-04-07
ZA983806B (en) 1999-02-19
DE69813083T2 (de) 2004-05-27
EP0884054B1 (en) 2003-04-09
AU735404B2 (en) 2001-07-05
CA2234899C (en) 2004-08-10
EP0884054A3 (en) 2000-08-23
TR199800847A3 (tr) 1999-10-21
TR199800847A2 (xx) 1999-10-21
BR9805597A (pt) 2000-04-11
SK284337B6 (sk) 2005-02-04
AR011730A1 (es) 2000-08-30
CN1146418C (zh) 2004-04-21
ES2197443T3 (es) 2004-01-01
HU9801075D0 (en) 1998-07-28
NO982112D0 (no) 1998-05-08
SK61698A3 (en) 1998-12-02
HUP9801075A3 (en) 2000-12-28
JP3576806B2 (ja) 2004-10-13
CA2234899A1 (en) 1998-11-13
JPH11124330A (ja) 1999-05-11
PT884054E (pt) 2003-08-29
IL124253A (en) 2003-01-12
EP0884054A2 (en) 1998-12-16
TW562679B (en) 2003-11-21
HUP9801075A2 (hu) 1999-01-28
PL326246A1 (en) 1998-11-23
RU2182002C2 (ru) 2002-05-10
ATE236653T1 (de) 2003-04-15
NO315545B1 (no) 2003-09-22
ES2125198B1 (es) 1999-11-16
DE69813083D1 (de) 2003-05-15
CZ292616B6 (cs) 2003-11-12
PL192117B1 (pl) 2006-09-29
ES2125198A1 (es) 1999-02-16
NZ330447A (en) 1998-12-23

Similar Documents

Publication Publication Date Title
AU3917400A (en) Athletic apparatus and method of use
PL317930A1 (en) Oxalydine compounds, method of obtaining them and therapeutic agents
PL367272A1 (en) Novel substituted benzimidazole dosage forms and method of using same
IS2595B (is) Prótínblanda og ferli til að einangra prótínblöndu úr vöðvavef
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
PL332432A1 (en) Oxadiazoles, method of obtaining them as well as their application as therapeutic agents
HUP9803018A3 (en) Use of cyclooxygenase-2 inhibitors for producing pharmaceutical compositions suitable for the treatment and prevention of tumors, tumor-veloted disorders and cachexia
ID26861A (id) Terapi gabungan untuk pengobatan depresi refaktori
PL325322A1 (en) Novel substituted amine compounds, method of obtaining them and therapeutic agent
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
DK0991415T3 (da) Faste, oralt indgivelige dosisformer for ribavirin og fremgangsmåde til fremstilling af disse
ID28894A (id) Metoda dan komposisi untuk perlakuan terhadap penyakit gangguan gastro-esophageal
NO982112D0 (no) Fiksert-dosesammensetning av en angiotensinkonverterende enzyminhibitor og en kalsiumkanalantagonist, fremgangsmÕte for dens fremstilling og anvendelse derav i behandling av kardiovaskulµre sykdommer
AU2003210871A8 (en) Mixed steroidal 1,2,4,5-tetraoxane compounds and methods of making and using thereof
MXPA01007952A (es) Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.
HUP0102772A2 (hu) Alfa-D-xilózból származó vegyületek, eljárás előállításukra és gyógyászati alkalmazásuk
EP1009433A4 (en) THERAPEUTIC COMPOSITION AND TREATMENT METHOD
AU3632899A (en) Method for the therapeutic and prophylactic treatment of dental diseases
AU9294698A (en) Methods and compositions for enhanced wound healing
AU2003257370A1 (en) Methods of treating benzodiazepine site (bzd-s) associated syndromes using 2' hydroxyflavonoids
DK1047668T3 (da) Triazepinoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf
EP1671630A3 (en) L-Arginine based formulations for treating diseases and methods of using the same
AU2003202461A1 (en) Combination therapy of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist for treatment of cardiovascular disease
AUPP203498A0 (en) A healing enhancing composition and method of treatment using same
AUPP179098A0 (en) A healing enhancing composition and method of treatment of using same

Legal Events

Date Code Title Description
MK1K Patent expired